1Lazarou J,Pomeranz BH,Corey PN.Incidence of adverse drug reactions in hospitalized patients:a meta-analysis of prospective studies[J].JAMA,1998,279(15):1200.
3Venkatakrishnan K,Moltke L,Scott OR,et al.Drug metabolism and drug interactions:application and clinical value of in vitro models[J].Curr Drug Metab,2003,4(5):423.
4Masimirembwa CM,Thompson R,Andersson TB.In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery[J].Comb Chem High T Scr,2001,4(3):245.
5Bjornsson TD,Callaghan JT,Einolf HJ,et al.The conduct of in itro and in vivo drug-drug interaction studies:a PhRMA perspective[J].J Clin Pharmcol,2003,43(5):443.
6Ekins S,Ring BJ,Grace J,et al.Present and future in vitro approaches for drug metabolism[J].J Pharmacol Toxicol,2000,44(1):313.
8Cohen L,Remly M,Raunig D,et al.In vitro drug interactions of cytochrome P450:an evaluation of fluorogenic to conventional substrates[J].Drug Metab Dispos,2003,31(8):1005.
9Yuan R,Madani S,Wei XX,et al.Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions[J].Drug Metab Dispos,2002,30(12):1311.
1[1]Lazarou J,Pomeranz BH,Corey PN.Incidence of adverse drug reactions in hospitlized patients:ammeta-analysis of prospective studies[J].JAMA,1998,279(15):1200
3[4]Friedman MA,Woodcock J,Lumpkin MM,et al.The safety of newly approved medicines-Dorecent market removals mean there is a problem[J].JAMA,1999,281(18):1728
4[5]Mullins ME,Horowitz BZ,Linden DH,et al.Life-threatening interaction of mibefradilol and β-blockers with dihydropyridine calcium channel blockers[J].JAMA,1998,280(2):157
5[8]Rodrigues AD.Preclinical drug metabolism in the age of high-throughput screening:an industrial perspective[J].Pharm Res,1997,14(11):1504
6[9]Yuan R,Parmelee T,Balian JD,et al.In vitro metabolic interaction studies:Expenience of the food and drug administration[J].Clin Pharmacol Ther,1999,66(1):9
7[10]Department of Health and Human Services,U.S.Food and Drug Administration[S].Drug metabolism/Drug interaction studies in the drug development process:Studies In Vitro.1997,April
8[11]Department of Health Services,Canada[S].Therapeutic products programme guidance document-drug-drug interactions: Studies in vitro and in vivo.2000,September,24
9[12]Bjornsson TD,Callaghan JT,Einolf HJ,et al.The conduct of in vitro and in vivo drug-drug interaction studies:a PhRMA perspective[J].J Clin Pharmacol,2003,43(5):443
10Bailey DG, Dresser DK, Kreeft JH, et al. Grapefruit felodipine interaction: effect of unprocessed fruit and probable active ingredients. Chin Pharmacol Ther 2000;68:468-477.
10Kokwaro GO,Glazier AP,Ward SA,Breckenridge AM,Edwards G.Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes.Biochem Pharmaco11993; 45:1235-1241.
